Clinical Trial Update: Prophylactic IV Paracetamol in Extremely Premature Infants [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial evaluated prophylactic intravenous paracetamol for prevention of patent ductus arteriosus in extremely premature infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus

Drugs mentioned

• Paracetamol (acetaminophen)

Snippet

Sponsor: Al-Quds University | Conditions: Patent Ductus Arteriosus in Preterm Infants, Patent Ductus Arteriosus After Premature Birth | Phase 2, Phase 3 | Status: COMPLETED